Market Access/ News/ News NICE firms up NHS use of Vimizim for Morquio A syndrome Phil Taylor BioMarin, HEOR, Morquio, NHS England, NICE, rare disease, Vimizim 0 Comment In 2015, NICE said that BioMarin’s Vimizim could be used to treat patients with the ultra-rare disease Morquio Share X NICE firms up NHS use of Vimizim for Morquio A syndrome https://pharmaphorum.com/news/nice-firms-up-nhs-use-of-vimizim-for-morquio-a-syndrome/
Articles/ Views and analysis Rare disease drug Vimizim gets NICE ‘yes’ – but needs real-world data Andrew McConaghie BioMarin, Morquio, NICE, Rare diseases, Vimizim 0 Comment NICE says it can approve BioMarin’s ultra-rare drug treatment Vimizim, but has proposed real-world data collection and a Share X Rare disease drug Vimizim gets NICE ‘yes’ – but needs real-world data https://pharmaphorum.com/views-and-analysis/rare-disease-drug-vimizim-gets-nice-yes/
BioMarin, HEOR, Morquio, NHS England, NICE, rare disease, Vimizim
0 Comment
